The role of positron emission tomography in the diagnosis of urologic malignancies

ABSTRACT

Fluorodeoxyglucose positron emission tomography (FDG-PET) has a limited role in the diagnosis of prostate cancer mainly because of the low uptake of FDG in the tumor. FDG-PET has shown some advantages in the assessment of lymph nodes and bone metastases. FDG-PET has a significant potential to assist with the diagnosis and management of testicular cancer. PET has been most useful in defining the presence or absence of disease in patients with residual masses. Role of PET in renal cell carcinoma and bladder cancer is so limited. Some new marked atoms have studied to increase effects of PET in diagnosis urologic malignancies